Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MDisrupt is a private healthtech company that operates an AI-powered marketplace and workflow platform connecting life sciences, digital health, diagnostics, medical device, and healthcare companies with vetted clinical, regulatory, commercial, reimbursement, and operational experts. The company’s offerings include hourly expert consultations, on-demand fractional operators, expert hiring, and clinician-in-the-loop support for healthcare AI development. Its platform automates expert matching, scheduling, transcripts, contracting, payments, and compliance workflows. Rather than developing therapeutic products, MDisrupt provides infrastructure and services that help healthcare innovators validate, build, commercialize, and scale products more efficiently. The business is positioned as a healthcare-enablement and expert-engagement platform serving both operating companies and investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MDisrupt.